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Abstract: The ancestral cultures have described many therapeutic properties of garlic; therefore, it is of central interest to
elucidate the molecular basis explaining this millenary empirical knowledge. Indeed, it has been demonstrated a
neuroprotective effect of allicin–a phytochemical present in garlic- linked to oxidative-inflammatory modulation.
Allicin improved neuronal injury by heat shock protein 70 (Hsp70) and inducible nitric oxide synthase (iNOS)
regulation. Also, allicin exerts renal protection involving a possible angiotensin type 1 receptor (AT1) interaction. In
connection, AT1 overexpression has been recognized as a central deleterious factor in many brain diseases. However,
there are no studies that evaluate AT1-Hsp70-iNOS interaction as a mechanism linked to neuroinflammation. Thus,
our central aim is to evaluate if the allicin protective effect is associated with an AT1-Hsp70-iNOS counterbalance
axis. For this study, a murine microglial cell line (BV-2) was injured with lipopolysaccharides and treated or not with
allicin. Then, it was evaluated cell viability, proinflammatory cytokine levels, cellular oxidative stress, iNOS, Hsp70,
and AT1 protein expression (cellular and mitochondrial fractions), nitrite levels, and protein-protein interactions. The
results demonstrated that allicin could prevent neuronal injury due to a reduction in oxidative stress and
inflammatory status mediated by an AT1-Hsp70-iNOS counterbalance axis linked to direct protein-protein interaction.
Introduction
A Recently, there are a lot of reports on the use of so-called
functional foods and their implications for human health,
where most of these studies refer to cardiovascular pathology
(Lonnie et al., 2020). Specifically, allicin (Alli) -an
organosulfur compound obtained from garlic- exhibits a
potent antihypertensive effect through vasodilatory properties
(Cui et al., 2020). Also, Alli was effective in wound healing in
an experimental diabetes model (Toygar et al., 2020). In
addition, Alli plays an important role in regulating energy
homeostasis, which provides a promising potential therapy
for obesity and metabolic disorders (Zhang et al., 2020).
However, it draws our attention that these alternative tools
are less explored in other pathologies of increasing global
expansion, such as those developed at the level of the central
nervous system (CNS). Recently has been demonstrated a
neuroprotection promissory effect of allicin (Alli) -an
organosulfur compound obtained from garlic- linked to
modulation of the oxidative stress, inflammation, and
apoptosis (Kong et al., 2017; Lv et al., 2015). In close
connection, diallyl trisulfide -another specific organosulfur
compound obtained from garlic- showed anti-
neuroinflammatory properties in lipopolysaccharide (LPS)-
stimulated BV-2 microglia (Ho and Su, 2014). This finding
stimulates us to deepen the knowledge of pathophysiological
aspects of neurological disorders as well as the development
of neurodegenerative diseases, and possibly to contribute with
new information for therapeutic approaches.
In this context, our laboratory and others discussed a
central hypothesis on neurotoxicity due to a close
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relationship between glutamatergic toxicity with altered
mitochondrial function and increased oxidative stress (Goracci
et al., 2010; Manucha, 2017; Son and Elliott, 2014). Indeed, all
these factors are widespread during the neuronal apoptosis
present in multiple chronic, inflammatory, and
neurodegenerative pathologies of the central nervous system
(Chabrier et al., 1999; Urrutia et al., 2014) where the nitric
oxide (NO) is a predominant effector of neurodegeneration. In
addition, the loss of an adequate mitochondrial function has
been related to alterations in calcium homeostasis and changes
in the glutamatergic pathway (Brown and Vilalta, 2015;
Takarada et al., 2013; Smaili et al., 2011). To emphasize cell
death is essential for the suitable development and maintenance
of the central nervous system; whereas, its mismatch has been
described in patients with neurodegenerative processes
associated with oxidative stress (Pchelina et al., 2014; Pinazo-
Durán et al., 2015).
It has recently been recognized that mitochondrial
dysfunction and NO levels would be responsible for many
processes of neurological toxicity, at least in part.
Consequently, a new finding closely related has been
discussed. More specifically, the authors suggest that inducible
nitric oxide synthase (iNOS) is modulated by heat shock
protein 70 (Hsp70) expression (Zlatković et al., 2014). In close
connection, Hsp70 is a suitable marker of cellular injury in the
nervous system after a neurotoxic stimulus (Rajdev and Sharp,
2000). Therefore, loss in the Hsp70 function linked to NO
overproduction could contribute to the development and
maintenance of neurodegenerative disorders (Nakamura and
Lipton, 2007). To reinforce, Liu and colleagues induced a
cellular injury with glutamate in the in vitro spinal cord
model. More specifically, the Alli treatment significantly
attenuated neuronal death by decrease iNOS expression with a
significantly increased in the Hsp70 expression (Liu et al.,
2015). Parallelly, it was reported -in chronic kidney disease-
that Alli exerts protection like to an angiotensin II receptor
inhibitor (AT1) losartan, and in silico analyses supported the
notion that Alli and losartan could have a common
mechanism involving interaction with AT1 (García et al.,
2017). These results are particularly interesting since it is
known that AT1 overexpression has been recognized as a
central and early deleterious factor in the development of
many brain diseases and, consequently, angiotensin receptor
blockers (ARBs) are outstanding candidates for the treatment
of brain disorders (Saavedra, 2017).
Collectively, we proposed to evaluate the following key
hypothesis: Alli prevents neuronal injury in the murine microglial
cell line -a cellular model of neurotoxicity- due to a reduction in
oxidative stress/inflammation mediated by an AT1-Hsp70-iNOS
counterbalance axis. If this is so, Alli may exert a critical and
fundamental anti-inflammatory/anti-oxidative role in neurological
disorders as well as the development of neurodegenerative
diseases. In addition, we also assessed whether this
counterbalance axis is associated with mitochondrial dysfunctions.
Materials and Methods
A cell culture and treatment
The BV-2 cells, a murine microglial cell line provided by
Centro Trasfusionale Banca Biologica and Cell Factory
IRCCS AOU (San Martino, IST L.go R. Benzi, 10 16132
Genoa, Italy), were cultured in RPMI 1640. The medium
was supplemented with 10% FBS, 100 U/mL penicillin, 100
μg/mL streptomycin in an atmosphere of 95% air, and 5%
CO2 at 37°C. The trypan blue method was used to
determine the number of viable cells (millions/mL). The
protocols were started after 24 h of cellular quiescence with
0.1% of FBS. BV-2 cells were injured or not with
lipopolysaccharides (LPS, 100 ng/mL), and BV-2 cells
injured with LPS and were co-treated or not with Alli (50
μM) for 72 h. The culture medium containing the LPS, Alli,
or both, was replaced every day. Each protocol (triplicate)
was replicated five to ten times. The treatments lasted
3 days, and finally, the cells were collected to perform the
specific determinations.
Alli specifications
Alli was synthesized by oxidation of diallyl disulfide (DADS)
with hydrogen peroxide following the previously reported
by the group (González et al., 2007). The synthesized Alli
were further isolated and purified by fractions collection
after HPLC separation using a normal phase Waters
Spherisorb S5W HPLC column and hexane: isopropanol
(92:8 v/v) as mobile phase. Then, collected fractions were
concentrated under reduced pressure and characterized by
UV-spectroscopy and GC-MS analyses. UV spectra were
obtained by using a Varian’s Cary 50 UV-Vis
Spectrophotometer, and quantification was carried out by
using the extinction coefficient (Lawson and Hughes, 1991).
For GC-MS analyses, a Perkin Elmer Clarus 500 was used.
Alli was confirmed by UV and mass spectra; the last, through
the confirmation of formed vinyldithiins. Obtained mass and
UV spectra agree with the bibliography (Lawson and Hughes,
1991; Ilić et al., 2012). Synthesized Alli was preserved in a
closed amber vial at −80°C (Locatelli et al., 2014).
Cell viability
The cell viability was performed by the MTT technique.
Concisely, upon completion of the pharmacological
treatment, BV-2 cells were loaded with MTT to a final
concentration of 1 mg/mL and incubated for 3 h at 37°C.
The chromogen formed was dissolved in DMSO, and the
optic density (OD) value measured at 570 nm was used to
index cell viability. The absorbance of the untreated BV-2
cells (Control) was also measured in order to calculate
relative cell viability (in percentage).
Proinflammatory cytokine levels
Proinflammatory cytokines levels were evaluated in the
culture medium by ELISA kit. TNF-α (ab208348, ABCAM)
and IL-1β (EK0394, Boster Biological Engineering and
Cloud-Clone Corp) values were determined according to the
manufacturer’s instructions.
Measure for cellular oxidative stress
After the pharmacological treatments, the fluorescent dye
dihydroethidium technique was performed to assess the
superoxide anion (O2
•−) production according to a previous
report without any modifications (Martínez-Martínez et al.,
2016). The levels of the superoxide anion are presented as
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an n-fold increase over the values of the control group. These
correspond to three assays, and each one was done for
quintuplicate.
Procedure to isolate mitochondria from BV-2 cultures
Cells (2 × 106) were added 5 mL of buffer (protease inhibitor
cocktail, 70 mM sucrose, 1 mM EDTA, 200 mM mannitol,
and 10 mM HEPES pH 7.4; Sigma, St. Louis, MO). The BV-
2 cells were homogenized with a Dounce glass homogenizer
(Wheaton, catalog no. 357544). The lysate was processed
according to a previous report (Prado et al., 2018). Finally,
we evaluate the purity of the mitochondrial fraction
obtained according to O’Beirne and Williams (1988).
NADPH activity assay
NADPH oxidase activity was measured in BV-2 cells and the
mitochondrial fractions of the BV-2 cells by means of the
Luminol (521-31-3, Sigma-Aldrich) technique, and where all
the procedures and reagents used were the same as previous
reports (Prado et al., 2018). The results were expressed as
arbitrary fluorescence units (AFU) per microgram of protein
and minute of incubation.
iNOS, Hsp70 and AT1 protein expression by western blot
technique
Protein expressions were measured both in BV-2 cells and the
mitochondrial fractions of the BV-2 cells. For both cases, all
procedures and reactions were the same as those used in
previous reports (Manucha and Vallés, 2008). The primary
antibodies used were: iNOS (sc-7271 mouse monoclonal,
dilution 1:2500), Hsp70 (sc-33575 rabbit polyclonal, dilution
1:1000), and AT1 (sc-31181 goat polyclonal, dilution 1:1000).
For cellular fraction, the housekeeping gene expression was
performed with anti-β-actin (sc-47778 mouse monoclonal
antibody, dilution 1:2000). For mitochondrial fraction, the
housekeeping gene expression was performed with anti-COX
IV (ab-16056 rabbit polyclonal antibody, dilution 1:1500).
The ratios of the immunosignal were standardized to 1 for
the corresponding control values (BV-2 cells and
mitochondrial fractions without treatment).
Immunofluorescence confocal microscopy
Cellular fixation, cryoprotection, as well as the
permeabilization procedures, were according to García et al.
(2012). The primary and secondary antibodies used, as well
as the processes and equipment, were the same as those
used in previously reported work by our laboratory. For
details, refer to García et al. (2014).
Determination of nitrite levels in BV-2 cells
We measured nitrite levels by Griess reaction. Homogenates
from lysed BV-2 cells were processed according to a
previous report (Mazzei et al., 2010). The nitrites levels were
determined by a spectrophotometer (540 nm). Results were
expressed as nmol of nitrite generated per μg protein per
100 μL homogenate.
Protein-protein interactions by immunoprecipitation technique
The immunoprecipitation was performed in BV-2 cells
injured or not with LPS and treated or not with Alli during
72 h to assess the possible physical interaction between
iNOS, Hsp70, and AT1. We carried out all procedures for
western blot technique as well as immunoprecipitation
according to previously published reports (García et al.,
2012). iNOS and AT1 expressions were adjusted to Hsp70
protein expression for all experimental conditions, and
results were expressed as a ratio. Finally, for guaranteed
specificity of immune-precipitation through anti-Hsp70
antibody, entire fractions were incubated with normal rabbit
immunoglobulin; and as a result, Hsp70 was not immune-
precipitated under any conditions (data not shown).
Statistical analysis
ANOVA II and Bonferroni post-test were used for the analysis
of the data. We considered a p < 0.05 as significant. The results
as the means ± SEM were processed by using GraphPad
Software, Inc., USA.
Results
Morphology and cell viability
Fig. 1 shows the morphological variations happening in
BV-2 cells activation subsequent to LPS treatment (LPS).
On the contrary, BV-2 cells without treatment (Control)
exhibited the typical ramified morphology of inactive
microglia. However, simultaneous treatment with LPS
plus Alli (LPS+Alli) attenuated the LPS-induced
microglial activation; and consequently, BV-2 cells
returned to display the distinctive ramified cellular
structure of inactive microglia.
FIGURE 1. Effects of Allicin on LPS-induced microglia activation. Microscopy images are presented and showing the morphology from
control BV-2 cells (Control), LPS-treated BV-2 cells (LPS), and LPS-treated BV-2 cells co-treated with Allicin (LPS+Alli). The cells were
swelled, and the nucleus was prominent, whereas allicin exposure attenuated LPS-induced cellular changes. Images showed from one
experiment and representative of at least five independent experiments. Scale bar: 50 μm.
ALLICIN NEUROPROTECTIVE EFFECTS INVOLVES AT1-HSP70-INOS INTERACTIONS 673
The MTT assay showed that LPS at the final
concentration of 100 ng/mL resulted in a reduction in mean
cell viability of BV-2 microglia (80 ± 5 vs. 100 ± 10; LPS vs.
Control; p < 0.05). Meanwhile, the treatment with Alli had a
positive effect on the viability of BV-2 cells. Specifically, BV-
2 cells were protected from the injury induced by LPS (95 ±
8 vs. 80 ± 5; LPS + Alli vs. LPS; p < 0.05) (Fig. 2). In
addition, treatment only with Alli did not modify the cell
morphology or viability when compared to control BV-2
cells (data not shown).
Oxidative stress and inflammatory response linked to NADPH
oxidase activity in BV-2 cells
ROS production linked to NADPH oxidase activity is a key
microglial response that often leads to neuronal toxicity. In
this sense, and since NADPH oxidase activity contributes to
the neurotoxicity/neuroinflammation associated with LPS,
we investigated if Alli might reduce microglial NADPH
oxidase activity and the following ROS production in BV-2
cells injured by LPS. As results, LPS caused a significant
increase in NADPH oxidase activity after 72 h of
stimulation (15000 ± 1500 vs. 10000 ± 1000; LPS vs.
Control; p < 0.01); while co-treatment with Alli (LPS+Alli)
reduced NADPH oxidase activity, returning it almost to the
control (12000 ± 1000 vs. 15000 ± 1500; LPS+Alli vs. LPS;
p < 0.05) (Fig. 3A). Additionally, according to the evidence
that mitochondria are the main source of ROS production,
we demonstrate that mitochondrial NADPH oxidase activity
was significantly higher in LPS treatment than it was in the
control cells (12000 ± 1200 vs. 8000 ± 1500; LPS vs.
Control; p < 0.01). On the contrary, the mitochondrial
fraction from BV-2 cells Alli-treated showed a lower
NADPH oxidase activity compared to mitochondrial
fraction from BV-2 cells with LPS-treated (10000 ± 1000 vs.
12000 ± 1200; LPS+Alli vs. LPS; p < 0.05) (Fig. 3B).
Consistently, in DHE assay, the fluorescence intensity
was higher in LPS-treated BV-2 cells than in control (200 ±
10 vs. 100 ± 10; LPS vs. Control; p < 0.01), suggesting
higher levels of O2
•− during LPS-induced microglial
activation. However, the treatment with Alli prevented the
altered O2
•− production in the LPS-induced microglial
activation (130 ± 20 vs. 200 ± 10; LPS+Alli vs. LPS; p <
0.01) (Fig. 3C). The Alli treatment alone did not modify
levels of O2
•− in control cells (data not shown).
Parallelly, the pro-inflammatory cytokine levels were
determined in the culture medium from BV-2 cells. Tab. 1
shows that both TNF-α, as well as IL-1β levels, were
significantly increased in the culture medium of LPS-treated
BV-2 cells (1500 ± 100 vs. 110 ± 20 and 150 ± 20 vs. 50 ±
10; LPS vs. Control; p < 0.001 and p < 0.01; TNF-α and
IL-1β levels, respectively). However, the treatment with Alli
significantly inhibited the production of TNF-α as well
IL-1β (500 ± 50 vs. 1500 ± 100 and 100 ± 20 vs. 150 ± 20;
LPS+Alli vs. LPS; p < 0.001 and p < 0.05; TNF-α and IL-1β
levels, respectively).
Allicin effects on AT1, Hsp70, iNOS expression and nitrite levels
in BV-2 cells
Firstly, we demonstrated a higher iNOS protein expression
from BV-2 cells treated with LPS (LPS) related to BV-2 cells
without treatment (Control) (2.5 ± 0.2 vs. 1.00 ± 0.1; LPS vs.
Control; p < 0.001). Conversely, after 72 h of Alli treatment,
decreased iNOS protein levels were shown in BV-2 cells
co-treated with LPS (LPS+Alli) compared to LPS alone
(LPS) (1.5 ± 0.4 vs. 2.5 ± 0.2; LPS+Alli vs. LPS; p < 0.01)
(Fig. 4). The immunofluorescence analyses reinforce results
from western blot iNOS protein expression (Fig. 5). In
addition, increased nitrite levels were shown in BV-2 cells
treated with LPS (LPS) compared to non-treated BV-2 cells
(Control) (200 ± 15 vs. 100 ± 10 nmol NO2 generated/μg
protein/100 μL homogenate; LPS vs. Control; p < 0.001).
Alli treatment reduced nitrite levels in BV-2 cells co-treated
with LPS (LPS+Alli) compared to LPS alone (LPS) (130 ±
15 vs. 200 ± 15 nmol NO2 generated/μg protein/100 μL
homogenate; LPS+Alli vs. LPS; p < 0.01) (Fig. 6). In a
second step, and to validate/compare our protocol—respect
to previous findings—on the relationship between the iNOS
and Hsp70 proteins as well as the Alli effect on these, we
simultaneously tested the Hsp70 expression. In this sense,
we found lower Hsp70 level in BV-2 cells treated with LPS
(LPS) compared to non-treated BV-2 cells (Control) (0.2 ±
0.1 vs. 1.00 ± 0.15; LPS vs. Control; p < 0.001). Contrariwise,
after Alli treatment, an increased Hsp70 protein levels were
shown in BV-2 cells co-treated with LPS (LPS+Alli) compared
to LPS alone (LPS) (0.6 ± 0.1 vs. 0.2 ± 0.1; LPS+Alli vs. LPS;
p < 0.01) (Fig. 4). Parallel, we proceeded to determine the
AT1 protein levels. In the same way as what is established for
iNOS, we found a higher AT1 level in BV-2 cells treated with
LPS (LPS) related to BV-2 cells without treatment (Control)
(3 ± 0.2 vs. 1.00 ± 0.09; LPS vs. Control; p < 0.001). While,
after Alli treatment, a decreased AT1 protein levels were
shown in BV-2 cells co-treated with LPS (LPS+Alli) compared
to LPS alone (LPS) (1.8 ± 0.3 vs. 3 ± 0.2; LPS+Alli vs. LPS;
p < 0.01) (Fig. 4). All these results were confirmed by
immunofluorescence assays (Fig. 5).
To highlight, we were able to demonstrate that protein
expressions -in mitochondrial fractions- were consistent
with cellular expressions. More specifically, as shown in
FIGURE 2. BV-2 cells viability. Control bar represents viability (%)
in 72 h of control BV-2 cells. LPS bar represents viability (%) in 72 h
of LPS-treated BV-2 cells. The LPS+Alli bar represents viability (%)
in 72 h of LPS-treated BV-2 cells co-treated with Allicin. The
results were expressed as means ± SEM of 5 independent
observations. *p < 0.05 vs. Control, and #p < 0.05 vs. LPS.
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FIGURE 3.Oxidative stress in LPS-injured BV-2 cells: Allicin effect. A-NADPH oxidase activity in BV-2 cells. Control bar represents NADPH
oxidase activity (arbitrary fluorescence units, AFU) in 72 h of control BV-2 cells. LPS bar represents NADPH oxidase activity (AFU) in 72 h of
LPS-treated BV-2 cells. The LPS+Alli bar represents NADPH oxidase activity (AFU) in 72 h of LPS-treated BV-2 cells co-treated with Allicin.
The results were expressed as means ± SEM of 5 independent observations. **p < 0.01 vs. Control, and # p < 0.05 vs. LPS. B-NADPH oxidase
activity in mitochondrial fractions from BV-2 cells. Control bar represents NADPH oxidase activity (AFU) from the mitochondrial fraction in
72 h of control BV-2 cells. LPS bar represents NADPH oxidase activity (AFU) from the mitochondrial fraction in 72 h of LPS-treated BV-2
cells. The LPS+Alli bar represents NADPH oxidase activity (AFU) from the mitochondrial fraction in 72 h of LPS-treated BV-2 cells co-treated
with Allicin. The results were expressed as means ± SEM of 5 independent observations. **p < 0.01 vs. Control, and #p < 0.05 vs. LPS. C-
Superoxide anion production in BV-2 cells. Upper panel: Representative microphotographs of control BV-2 cells (Control), stimulated
with LPS (LPS), and stimulated with LPS in presence of Allicin (LPS+Alli) labeled with DHE. Lower panel: Control bar represents the
quantification of superoxide anions in 72 h of control BV-2 cells. LPS bar represents the quantification of superoxide anions in 72 h of
LPS-treated BV-2 cells. The LPS+Alli bar represents the quantification of superoxide anions in 72 h of LPS-treated BV-2 cells co-treated
with Allicin. The results were expressed as means ± SEM of 5 independent observations. **p < 0.01 vs. Control, and ##p < 0.01 vs. LPS.
TABLE 1
Effects of Allicin on pro-inflammatory cytokine production in BV-2 cells. The results were expressed as means ± SEM of 5 independent
observations. ***p < 0.001 and **p < 0.01 vs. Control; and ###p < 0.001 and #p < 0.05 vs. LPS.
Treatments Pro-inflammatory cytokines
TNF-α (pg/mL) IL-1β (pg/mL)
Control 110 ± 20 50 ± 10
LPS 1500 ± 100*** 150 ± 20**
LPS + Alli 500 ± 50### 100 ± 20#
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Fig. 7, we established a higher mitochondrial iNOS protein
expression from BV-2 cells treated with LPS (LPS) related to
BV-2 cells without treatment (Control) (2.0 ± 0.1 vs. 1.00 ±
0.2; LPS vs. Control; p < 0.001). Conversely, after Alli
treatment, a decreased in the iNOS protein level was shown
in BV-2 cells co-treated with LPS (LPS+Alli) compared to
LPS alone (LPS) (0.9 ± 0.1 vs. 2.0 ± 0.1; LPS + Alli vs. LPS;
p < 0.001).
Concurrently we tested the mitochondrial Hsp70 protein
expression. In this sense, we found lower mitochondrial
Hsp70 level in BV-2 cells treated with LPS (LPS) related to
BV-2 cells without treatment (Control) (0.2 ± 0.1 vs. 1.00 ±
0.15; LPS vs. Control; p < 0.001). Inversely, after Alli
treatment, increased mitochondrial Hsp70 protein levels
were shown in BV-2 cells co-treated with LPS (LPS+Alli)
compared to LPS alone (LPS) (0.6 ± 0.1 vs. 0.2 ± 0.1; LPS
+Alli vs. LPS; p < 0.01). Parallelly, we found a higher
mitochondrial AT1 expression in BV-2 cells treated with
LPS (LPS) related to BV-2 cells without treatment (Control)
(2.3 ± 0.2 vs. 1.00 ± 0.1; LPS vs. Control; p < 0.001). While,
after Alli treatment, decreased mitochondrial AT1 protein
levels were shown in BV-2 cells co-treated with LPS (LPS
+Alli) related to LPS alone (LPS) (1.2 ± 0.1 vs. 2.3 ± 0.2;
LPS + Alli vs. LPS; p < 0.001). With special attention to the
effect produced by Alli and as a result of the comparison
between mitochondrial versus cellular protein expressions,
emerge a more significant impact at the mitochondrial level.
To highlight, treatment only with Alli did not modify AT1,
Hsp70, iNOS expression, and nitrite levels in BV-2 cells
when compared to control BV-2 cells (data not shown).
iNOS-Hsp70-AT1 interactions in BV-2 cells
To further evaluate the possible interaction between iNOS-
Hsp70 as well as AT1-Hsp70, coimmunoprecipitation was
performed. Moreover, we also assess the hypothesis that
Hsp70 would be less associated with iNOS and with AT1
after treatment with Alli in BV-2 cells LPS-stimulated.
Cellular extracts fromBV-2 cells (Control, LPS, and LPS+Alli)
were immunoprecipitatedwith theHsp70 antibody and analyzed to
evaluate the presence of coprecipitated proteins iNOS as well as
AT1. Relevant for our study, we verify the interactions of iNOS-
Hsp70 and AT1-Hsp70 under Control and experimental
conditions (LPS and LPS+Alli) (Fig. 8). Our second finding was
that the LPS treatment produced a significant increase in the
iNOS-Hsp70 as well AT1-Hsp70 ratios in relation to proteins
ratio from untreated BV-2 cells (5.2 ± 0.6 vs. 1.0 ± 0.1 and 4.3 ±
0.5 vs. 1.0 ± 0.2; LPS vs. Control; p < 0.001).
The third instance of our study was to delineate whether
Alli could be implicated in the iNOS, AT1, and Hsp70
proteins interactions. In this sense, we established that the
Alli co-treatment in LPS-stimulated BV2 cells produced a
significant decrease in the iNOS-Hsp70 as well AT1-Hsp70
ratios with respect to proteins ratio from LPS-treated BV2
cells (1.5 ± 0.4 vs. 5.2 ± 0.6 and 1.8 ± 0.6 vs. 4.3 ± 0.5; LPS
+ Alli vs. LPS; p < 0.01) (Fig. 8).
Discussion
In the present work, anti-inflammatory/neuroprotective
proprieties of Alli were demonstrated in LPS-stimulated
BV2 microglia, as well as one new possible mechanism by
which Alli exerts its effects. As neuroinflammation is a
crucial process in the pathophysiology of many chronic
neurodegenerative and neuropsychiatric diseases, a deep
understanding of the underlying molecular mechanisms is
needed (Kong et al., 2017).
FIGURE 4. Allicin effects on AT1, Hsp70, iNOS expression by
western blot technique in BV-2 cells. (A) Representative blot of
AT1, Hsp70, and iNOS proteins expression in control BV-2 cells
(Control), stimulated with LPS (LPS) and stimulated with LPS in
the presence of Allicin (LPS+Alli). The β-actin protein expression–
as a housekeeping gene–is shown in the same order as the
densitometry bars. (B) The levels of AT1, Hsp70, and iNOS
proteins were established after normalization of the appropriate
control: 1. The results were expressed as means ± SEM of 5
independent observations. ***p < 0.001 vs. Control, and ##p < 0.01
vs. LPS.
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Of interest, among the functional foods, garlic (Allium
sativum L., family Liliaceae) contains rich sulfur-containing
amino acids, and it has been used as important traditional
Chinese medicine (Farooqui and Farooqui, 2018). In
addition, it was also demonstrated there is topical use of the
allicin and alliin (Toygar et al., 2020; Sardari et al., 2006).
If fresh garlic is chopped or crushed, alliin (the most
abundant free amino acid in garlic) gets in contact with the
enzyme alliinase that converts alliin to diallyl-dithiosulfinate
(Alli). Alli could cross the blood–brain barrier, and several
studies evidence its anti-inflammatory/neuroprotective,
antidepressant, and pro-cognitive actions (Xiang et al., 2017;
Zhang et al., 2018; Mocayar Marón et al., 2020). However,
not all the molecular mechanisms that justify such
protective effects are fully understood.
The microglial cells show an extremely versatile behavior;
that is the reason why the structure is in intimate relation to its
phagocytic function (Kettenmann et al., 2011). In this sense, the
present study demonstrates, for the first time, the effect of Alli
on the morphology of microglial cells. Resident microglial cells
(also known as “resting microglia”) can transform after LPS
from a ramified form to an amoeboid form and acquire a
proinflammatory phenotype (Fernández-Arjona et al., 2017).
Alli attenuated the LPS-induced microglial activation and,
consequently, BV-2 cells return to exhibit the typical ramified
morphology of resident microglia. Indeed, the phenotypic
microglial morphology recovery by Alli treatment could be
related to changes in cytoskeletal proteins. In close
connection, a recent proteomic analysis showed that Alli
produces post-translational modifications of type
S-thioallylation in various proteins, including proteins related
to actin filaments (Gruhlke et al., 2019). Moreover, Alli
induces disruption of the actin cytoskeleton in mouse
fibroblasts. However, the fibroblasts lost their actin-dependent
extensions and showed a mostly spheroidal morphology. An
altered dynamic of Actin affects the proinflammatory activity
of the microglia stimulated by LPS (e.g., reduced NO
secretion, iNOS expression, and reduced release of TNF-α
and IL-6) (Uhlemann et al., 2016). In the same way, we have
shown in BV2 LPS-injured cells that Alli can modulate the
NO levels, iNOS expression, proinflammatory cytokines,
oxidative stress, as well as AT1 expression.
The renin-angiotensin-aldosterone system (RAAS)
emerges as a possible target of the Alli mechanism of action
FIGURE 5. Allicin effects on AT1, Hsp70, iNOS expression by immunofluorescence technique in BV-2 cells. Immunofluorescence of AT1,
Hsp70, and iNOS in BV-2 cells stimulated with LPS (LPS), and in BV-2 cells stimulated with LPS in the presence of Allicin (LPS+Alli). Colors
reference: AT1 and iNOS (red), Hsp70 (green), and Hoechst 33342 stained nucleus (blue). Column 4 shows the merged images of the
differential interference contrast image (DIC) and Hoechst 33342 stained nucleus (blue). Images are representative of five different
experiments. Magnification 600X.
ALLICIN NEUROPROTECTIVE EFFECTS INVOLVES AT1-HSP70-INOS INTERACTIONS 677
since it plays a crucial role in microglial polarization, and
Angiotensin II (via AT1 receptor and NADPH activation)
induce a pro-inflammatory microglial phenotype
(Labandeira-Garcia et al., 2017). RAAS over-activation has
been associated with inflammation and mitochondrial
dysfunction. Here, and of particular interest, we show -in
total cellular lysate as well as in mitochondrial fraction from
BV2 cells- that LPS increases the expression of AT1 and
iNOS, while Alli was capable of reversing these effects.
Consistently, in silico modeling and docking analysis
suggests that Alli might act as a potent AT1 antagonist even
more effective than losartan (García et al., 2017).
Microglia has a variety of functions in the brain,
including synaptic pruning, CNS repair, and mediating the
immune response. Depending on the magnitude of the
injury, microglia can contribute to host defense and repair.
Microglia can transform into proinflammatory/classically
activated (M1) or anti-inflammatory/alternatively activated
(M2) phenotypes following environmental signals related to
physiological conditions or lesions (such as LPS). As
previously mentioned, several recent studies have shown
interactions between the brain RAAS and different factors
involved in microglial polarization. The locally formed
angiotensin is involved in local pathological changes of these
tissues and modulates immune cells, which are equipped
with all the RAAS components. Metabolic reprogramming
has recently been involved in the regulation of the
neuroinflammatory response. Interestingly, it was recently
observed a mitochondrial RAAS, which is altered in aged
brains. Dysregulation of brain RAAS plays a significant role
in aging-related changes and neurodegeneration by
exacerbating oxidative stress and neuroinflammation, which
may be attenuated by pharmacological manipulation of
RAAS components (Labandeira-Garcia et al., 2017). In this
sense, our results are consistent with the current literature
because Alli could modulate the local immune response
involved in tissue reaction after LPS injury due to a lower
expression of AT1 receptors (both at the cellular level and at
the mitochondrial level) associated with AT1-Hsp70-iNOS
counterbalance axis. Interestingly, Alli modulates the
lymphocytes' immune response via scavenger receptors
(Toma et al., 2019); in close connection, the scavenger
receptors are downregulated by the RAAS. In detail, the
phosphatidylinositol 3-kinase/Akt/FoxO1 pathway
participates in angiotensin II suppression of hSR-BI/CLA-1
expression and suggests that the RAAS downregulates the
endothelial receptor for hSR-BI/CLA-1. (Yu et al., 2007).
Alli attenuates LPS‑induced acute injury via the PI3K/Akt
pathway (Wang et al., 2018). Also, Alli inhibited
FIGURE 6. Allicin effects on nitrite levels in BV-2 cells.
Measurement of nitrite generated (nmol NO2 generated/μg
protein/100 μL homogenated). Control bar represents the
quantification of nitrite in 72 h of control BV-2 cells. LPS bar
represents the quantification of nitrite in 72 h of LPS-treated BV-2
cells. The LPS+Alli bar represents the quantification of nitrite in 72
h of LPS-treated BV-2 cells co-treated with Allicin. The results were
expressed as means ± SEM of 5 independent observations. ***p <
0.001 vs. Control, and ##p < 0.01 vs. LPS.
FIGURE 7. Allicin effects on AT1, Hsp70, iNOS expression by
western blot technique in mitochondrial fractions from BV-2 cells.
(A) Representative blot of AT1, Hsp70, and iNOS proteins
expression in the mitochondrial fraction from: control BV-2 cells
(Control), stimulated with LPS (LPS), and stimulated with LPS in
the presence of Allicin (LPS+Alli). Expression levels of the
mitochondrial electron transport complex IVc (Complex IVc)–as a
housekeeping gene–is shown in the same order as the densitometry
bars. (B) The levels of AT1, Hsp70, and iNOS proteins were
established after normalization of the appropriate control: 1. The
results were expressed as means ± SEM of 5 independent
observations. ***p < 0.001 vs. Control, ##p < 0.01, and ###p < 0.001
vs. LPS.
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interleukin-1β (IL-1β) induced overproduction of NO, iNOS,
prostaglandin E2, and cyclooxygenase-2, as well as pro-
inflammatory cytokines tumor necrosis factor-alpha and
interleukin-6 in a dose-dependent manner by PI3K/Akt/NF-
κB downregulation (Qian et al., 2018).
On the other hand, as previously mentioned,
mitochondrial dysfunction and NO levels would be
responsible for many processes of neurological toxicity; and
in agreement, Hsp70 may protect by downregulation of iNOS
protein expression (Zlatković et al., 2014); in where Hsp70
could be considered as a suitable marker of cellular injury in
the nervous system after a neurotoxic stimulus. To highlight,
our present findings have shown an Hsp70 lower expression
after LPS stimulation, and the opposite happened (according
to Liu et al., 2015) in the cells co-treated with Alli. Moreover,
and for the first time, stress markers, as well as total cellular
protein expressions, were consistent with mitochondrial
fractions. These results could suggest that Alli could
contribute to the restoration of mitochondrial dynamics.
In order to evaluate the anti-inflammatory properties of
Alli, pro-inflammatory cytokine levels and oxidative
biomarkers were measured in BV-2 cells after treatment
with LPS. As previously mentioned and consistent with the
data published in the literature (Ho and Su, 2014), the
treatment with Alli significantly inhibited the production of
TNF-α, IL-1β, nitrites as well as the NADPH oxidase
activity. Reinforcing our results, Alli also decreases the levels
of proinflammatory mediators after LPS treatment in other
cell types as chondrocytes (Qian et al., 2018), human
umbilical vein endothelial cells (Zhang et al., 2017), and
lung cells (Zheng et al., 2014), among others.
Finally, our findings led us to consider the possibility of
protein–protein interaction as part of the protective
mechanism Alli-mediated. The potential physical interaction
between iNOS, Hsp70, and AT1 proteins was done by
immunoprecipitation in BV-2 cells injured with LPS treated or
not with Alli. As outstanding results, we find first that there
are interactions between the proteins AT1-Hsp70 and iNOS-
Hsp70, second and fundamental to our hypothesis that these
protein interactions are altered in BV2 cells LPS-injured.
While on the contrary, Alli can reverse protein interactions.
New studies should deepen the knowledge about protein
interactions associated with changes in their cellular functions.
Together and based on the finding showed above, we
suggested that Alli avoids the neuronal injury in BV2 cells
-a cellular model of neurotoxicity- by a reduction in
oxidative stress/inflammation linked to an AT1-Hsp70-
iNOS counterbalance axis (graphical overview). More
specifically, Alli may exert a key protective role in
neurological disorders as well as the development of
neurodegenerative diseases. To highlight, we demonstrated
also whether this counterbalance axis is associated with
mitochondrial dysfunctions.
Graphical Overview. A new proposed neuroprotective
mechanism of allicin during the neuroinflammatory process
could be related to changes in the levels and iNOS-Hsp70-
AT1 protein-protein interactions.
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